Dongguan, Guangdong 523927, China[email protected]+86 136 3262 5290
Home/Iontophoresis Patches
Printed and converted platforms for controlled OEM integration

Custom Iontophoresis Electrode Patch Components

Iontophoresis patches combine an electrical path, active and return electrode zones, reservoir or interface media, skin-contact materials, packaging, electronics, and often a drug-device or treatment-specific regulatory strategy. JASPER supports only the quoted printed and converted component boundary against OEM-controlled artwork and specifications.

Review the System Boundaries
  • Dual-zone architectureActive, return, guard, routing, reservoir, adhesive, and keep-out regions follow artwork
  • Printed conductorsSpecified silver, Ag/AgCl, carbon, dielectric, substrate, tail, and contacts can be reviewed
  • Converted patch layersSpacer, reservoir boundary, skin adhesive, liner, backing, pull tab, and packaging interface are planned
  • OEM-owned deliveryDrug, dose, current, treatment, biological safety, electronics, and clinical claims remain outside component assumptions
Direct answer

An iontophoresis patch component cannot define dose delivery without the complete electrical and formulation system.

JASPER can print and convert electrode patch platforms with defined active and return zones, conductors, dielectric, spacers, adhesive patterns, liners, tails, and connectors. The OEM or legal manufacturer controls formulation, polarity, current profile, dose, reservoir loading, release kinetics, controller, risk management, biological safety, packaging, shelf life, use instructions, and finished-device or combination-product validation.

  • Define active and return electrode identity, polarity, area, spacing, current path, reservoir boundary, and accessible surfaces.
  • State whether formulation, hydrogel, drug loading, reservoir filling, final sealing, and sterile processing are included or excluded.
  • Evaluate uniformity, edge effects, leakage paths, adhesion, heating, skin interface, controller, and use conditions at finished-system level.
  • Lock materials, print layers, conversion, packaging, storage, and change control to the OEM validation baseline.
Exploded printed iontophoresis patch layer stack with electrode spacer adhesive and liner
Patch development flow

Four gates for an iontophoresis component with explicit ownership

The most serious errors occur when a manufacturing drawing hides formulation, electrical, skin-contact, or packaging assumptions that belong to another owner.

01

Intended system definition

Identify intended treatment or research use, active and return function, formulation owner, current controller, body site, contact duration, environment, user, packaging, shelf life, standards, and legal manufacturer.

02

Component and reservoir design

Release conductor and dielectric artwork, materials, electrode areas, spacer or reservoir geometry, adhesive, backing, liner, tail, connector, polarity marking, outline, datums, filling and sealing boundaries.

03

Production-intent correlation

Build the quoted dry or loaded component stage, inspect dimensions, registration, circuit, connector, reservoir and adhesive geometry, assembly and packaging fit, then correlate with OEM current and delivery studies.

04

Controlled production handoff

Maintain active files, material and lot identity, process and inspection records, loading or downstream handoff, packaging, storage, approved references, deviations, and change notification.

Ownership matrix

Define the patch boundary before assigning performance evidence

The same physical patch can behave differently with another formulation, controller, skin site, loading process, storage condition, or use duration.

System areaInputs to defineEvidence owner
Printed electrode componentInk and substrate, polarity, area, spacing, routing, dielectric, tail, connector, resistance, geometry and conversionJASPER within quoted manufacturing checks
Reservoir and formulationDrug or active material, vehicle, gel, membrane, loading, uniformity, compatibility, release and stabilityOEM/formulation and combination-product owner
Controller and energyCurrent profile, voltage compliance, monitoring, fault handling, contact detection, timing, cable and connectorOEM electrical and software validation
Skin use and final productBody site, duration, dose, adhesion, irritation, heating, packaging, shelf life, usability, labeling and clinical claimLegal manufacturer and finished-product validation
System and component inputs

Information needed to review an iontophoresis patch component

Confidential formulation details can remain controlled, but the manufacturing boundary and interfaces must be clear enough to prevent an unsafe assumption.

  1. 01Dimensioned active, return, guard, conductor, dielectric, reservoir, adhesive, liner, tail, and connector artwork
  2. 02Specified inks, films, spacers, adhesives, gels or interface media, backing, liner, label, and packaging materials
  3. 03Polarity, current and voltage envelope, controller, cable, connector, monitoring, and fault-response context
  4. 04Body site, contact type and duration, wear conditions, movement, moisture, temperature, and user handling
  5. 05Component, formulation, electrical, biological, delivery, packaging, aging, and usability validation plan
  6. 06Prototype and production quantities, downstream loading, legal manufacturer, records, and change control
FAQ

Iontophoresis patch component questions

Can JASPER manufacture active and return electrode zones in one patch?

JASPER can review multi-zone printed and converted artwork with defined materials, polarity, spacing, routing, dielectric, spacer, adhesive, tail, connector, and downstream reservoir or loading boundary.

Does JASPER supply the drug or formulation?

No such scope should be assumed. The RFQ must state whether formulation, gel, reservoir loading, sealing, packaging, or stabilization is customer-supplied, partner-managed, included, or excluded.

Can the patch be validated without the controller?

Component geometry and circuit checks can be performed, but delivery, heating, fault response, current distribution, dose, and treatment performance require the intended controller, loaded patch, placement, and use conditions.

What is needed for a first feasibility review?

Provide the zone artwork, stack, materials, reservoir and adhesive boundaries, tail and connector, electrical envelope, body-contact context, downstream loading, packaging, quantities, standards, and validation ownership.

Make the component boundary explicit before patch geometry becomes a delivery assumption.

Send the electrode and reservoir artwork, material stack, controller interface, contact conditions, downstream operations, quantities, and validation ownership for review.